您正在瀏覽的是香港網站,香港證監會BJA907號,投資有風險,交易需謹慎
市場資訊

市場資訊

首頁市場資訊個股相關資訊

Fate Therapeutics, Inc. (FATE)

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founde